Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products... Show more
Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KLMT | 29.16 | 0.45 | +1.57% |
| Invesco MSCI Global Climate 500 ETF | |||
| FLQM | 55.65 | 0.28 | +0.51% |
| Franklin US Mid Cap Mltfctr Idx ETF | |||
| XTJL | 36.74 | 0.09 | +0.26% |
| Innovator US Equity Acclrtd Pls ETF Jul | |||
| SLVP | 18.56 | -0.02 | -0.11% |
| iShares MSCI Global Silver&Mtls Mnrs ETF | |||
| BKF | 42.30 | -0.23 | -0.54% |
| iShares MSCI BIC ETF | |||
A.I.dvisor tells us that HLUBF and HLBBF have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLUBF and HLBBF's prices will move in lockstep.
| Ticker / NAME | Correlation To HLUBF | 1D Price Change % | ||
|---|---|---|---|---|
| HLUBF | 100% | N/A | ||
| HLBBF - HLUBF | 19% Poorly correlated | -3.38% | ||
| HLNCF - HLUBF | 7% Poorly correlated | -0.51% | ||
| ESAIY - HLUBF | 5% Poorly correlated | -0.28% | ||
| EAPIF - HLUBF | 0% Poorly correlated | N/A | ||
| BGLAF - HLUBF | -0% Poorly correlated | N/A | ||
More | ||||